Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-043030
Filing Date
2013-08-05
Accepted
2013-08-05 16:54:21
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 form461532_20130805045359-.html 4  
1 form461532_20130805045359-.xml 4 3704
  Complete submission text file 0001144204-13-043030.txt   5242
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIOPHARMA, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
GENERAL HILL (Ret) JAMES T. (Reporting) CIK: 0001441718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 131010810